Cite

HARVARD Citation

    Lewis, E. et al. (2020). A subset analysis of a phase II trial evaluating the use of DFMO as maintenance therapy for high‐risk neuroblastoma. International journal of cancer. 147 (11), pp. 3152-3159. [Online]. 
  
Back to record